Maternal Screening Control by Randox Laboratories Ltd.



Maternal Screening Control by Randox Laboratories Ltd. product image
Maternal Screening Control
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The Randox Acusera Maternal Screening quality control is the only commercially available control to cover all six analytes used during first and second trimester screening of Down’s syndrome and Spina Bifida. Assayed instrument specific target values and ranges are provided for AFP, β hCG, Inhibin A, PAPP-A, Total hCG and Unconjugated Estriol. The inclusion of Inhibin A and PAPP-A eliminates the need to purchase additional controls at extra expense.


Features & Benefits

  • Lyophilised for enhanced stability
  • 100% human serum
  • Assayed target values provided for 6 parameters
  • Suitable for double, triple and quad screens
  • Unconjugated Estriol present at clinically significant levels
  • Stable to expiry date at 2°C – 8°C
  • Reconstituted stability of 7 days at 2°C – 8°C

Description - Size - Analytes - Cat No

  • Maternal Screening Control Level 1 - 3 x 1 ml - 6 - MSS5024
  • Maternal Screening Control Level 2 - 3 x 1 ml - 6 - MSS5025
  • Maternal Screening Control Level 3 - 3 x 1 ml - 6 - MSS5026

Analytes:

  • AFP
  • PAPP-A
  • Free Beta hCG
  • Total hCG
  • Inhibin A
  • Unconjugated Oestriol